ACTINIUM PHARMACEUTICALS, INC. Basic Shares Outstanding (Weighted Average)
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Basic Shares Outstanding (Weighted Average) of 31.40 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 31.40M shares, a 0.65% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 31.24M shares, a 0.13% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 31.20M shares, a 0.03% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 31.20M shares, a 0.40% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 31.20M shares, a 3.74% increase from fiscal 2024.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 30.07M shares, a 13.03% increase from fiscal 2023.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 26.60M shares, a 10.20% increase from fiscal 2022.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 24.14M shares, a 17.37% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 31.40M shares 10-Q · filed 2026-08-07 | 31.32M shares 10-Q · filed 2026-08-07 | 31.28M shares derived: average of 3 quarters · filed 2026-08-07 | 31.26M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 31.24M shares 10-Q · filed 2026-05-08 | 31.22M shares derived: average of 2 quarters · filed 2026-05-08 | 31.21M shares derived: average of 3 quarters · filed 2026-05-08 | 31.21M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | 31.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 31.20M shares derived: average of 2 quarters · filed 2026-03-30 | 31.20M shares derived: average of 3 quarters · filed 2026-08-07 | 31.20M shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 31.20M shares 10-Q · filed 2025-11-14 | 31.20M shares derived: average of 2 quarters · filed 2026-08-07 | 31.20M shares 10-Q · filed 2025-11-14 | 31.20M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | 31.20M shares 10-Q · filed 2026-08-07 | 31.20M shares 10-Q · filed 2026-08-07 | 31.20M shares derived: average of 3 quarters · filed 2026-08-07 | 31.17M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | 31.20M shares 10-Q · filed 2026-05-08 | 31.20M shares derived: average of 2 quarters · filed 2026-05-08 | 31.16M shares derived: average of 3 quarters · filed 2026-05-08 | 30.89M shares derived: average of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | 31.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 31.14M shares derived: average of 2 quarters · filed 2026-03-30 | 30.79M shares derived: average of 3 quarters · filed 2026-03-30 | 30.07M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 31.07M shares 10-Q · filed 2025-11-14 | 30.59M shares derived: average of 2 quarters · filed 2025-11-14 | 29.69M shares 10-Q · filed 2025-11-14 | 29.12M shares derived: average of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | 30.10M shares 10-Q · filed 2025-08-08 | 28.99M shares 10-Q · filed 2025-08-08 | 28.47M shares derived: average of 3 quarters · filed 2025-08-08 | 28.12M shares derived: average of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | 27.89M shares 10-Q · filed 2025-05-09 | 27.66M shares derived: average of 2 quarters · filed 2025-05-09 | 27.46M shares derived: average of 3 quarters · filed 2025-05-09 | 27.15M shares derived: average of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | 27.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 27.24M shares derived: average of 2 quarters · filed 2025-03-31 | 26.90M shares derived: average of 3 quarters · filed 2025-03-31 | 26.60M shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 27.06M shares 10-Q · filed 2024-11-14 | 26.64M shares derived: average of 2 quarters · filed 2024-11-14 | 26.33M shares 10-Q · filed 2024-11-14 | 26.12M shares derived: average of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | 26.22M shares 10-Q · filed 2024-08-05 | 25.96M shares 10-Q · filed 2024-08-05 | 25.80M shares derived: average of 3 quarters · filed 2024-08-05 | 25.64M shares derived: average of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | 25.70M shares 10-Q · filed 2024-04-26 | 25.59M shares derived: average of 2 quarters · filed 2024-04-26 | 25.45M shares derived: average of 3 quarters · filed 2024-04-26 | 25.02M shares derived: average of 4 quarters · filed 2024-04-26 |
| 2022-12-31 | 25.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 25.33M shares derived: average of 2 quarters · filed 2024-03-29 | 24.80M shares derived: average of 3 quarters · filed 2024-03-29 | 24.14M shares 10-K · filed 2024-03-29 |
| 2022-09-30 | 25.16M shares 10-Q · filed 2023-11-02 | 24.45M shares derived: average of 2 quarters · filed 2023-11-02 | 23.69M shares 10-Q · filed 2023-11-02 | 23.28M shares derived: average of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | 23.73M shares 10-Q · filed 2023-08-14 | 22.94M shares 10-Q · filed 2023-08-14 | 22.66M shares derived: average of 3 quarters · filed 2023-08-14 | 22.38M shares derived: average of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | 22.14M shares 10-Q · filed 2023-05-15 | 22.12M shares derived: average of 2 quarters · filed 2023-05-15 | 21.93M shares derived: average of 3 quarters · filed 2023-05-15 | 21.50M shares derived: average of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 22.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 21.82M shares derived: average of 2 quarters · filed 2023-03-31 | 21.29M shares derived: average of 3 quarters · filed 2023-03-31 | 20.57M shares 10-K · filed 2023-03-31 |
| 2021-09-30 | 21.54M shares 10-Q · filed 2022-11-14 | 20.89M shares derived: average of 2 quarters · filed 2022-11-14 | 20.06M shares 10-Q · filed 2022-11-14 | |
| 2021-06-30 | 20.23M shares 10-Q · filed 2022-08-12 | 19.31M shares 10-Q · filed 2022-08-12 | ||
| 2016-09-30 | 47.65M shares 10-Q · filed 2016-10-28 | 47.06M shares derived: average of 2 quarters · filed 2016-10-28 | 46.13M shares 10-Q · filed 2016-10-28 | |
| 2016-06-30 | 46.47M shares 10-Q · filed 2016-07-29 | 45.36M shares 10-Q · filed 2016-07-29 | ||
| 2015-09-30 | 41.17M shares 10-Q · filed 2016-10-28 | 38.91M shares derived: average of 2 quarters · filed 2016-10-28 | 37.07M shares 10-Q · filed 2016-10-28 | |
| 2015-06-30 | 36.65M shares 10-Q · filed 2016-07-29 | 34.96M shares 10-Q · filed 2016-07-29 | ||
| 2014-06-30 | 25.80M shares 10-Q · filed 2015-08-07 | 25.51M shares 10-Q · filed 2015-08-07 | ||
| 2013-06-30 | 22.18M shares 10-Q · filed 2014-08-12 | 21.79M shares 10-Q · filed 2014-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |